Header Logo

Connection

Mehmet Altintas to Receptors, Urokinase Plasminogen Activator

This is a "connection" page, showing publications Mehmet Altintas has written about Receptors, Urokinase Plasminogen Activator.
  1. Soluble Urokinase Receptor and Acute Kidney Injury. N Engl J Med. 2020 01 30; 382(5):416-426.
    View in: PubMed
    Score: 0.174
  2. A tripartite complex of suPAR, APOL1 risk variants and av?3 integrin on podocytes mediates chronic kidney disease. Nat Med. 2017 Aug; 23(8):945-953.
    View in: PubMed
    Score: 0.145
  3. Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus. J Diabetes Res. 2017; 2017:3232848.
    View in: PubMed
    Score: 0.144
  4. Soluble Urokinase Receptor and Chronic Kidney Disease. N Engl J Med. 2015 Nov 12; 373(20):1916-25.
    View in: PubMed
    Score: 0.130
  5. The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney disease. Sci Transl Med. 2023 09 20; 15(714):eabq6492.
    View in: PubMed
    Score: 0.056
  6. Modification of kidney barrier function by the urokinase receptor. Nat Med. 2008 Jan; 14(1):55-63.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.